Article Details
Retrieved on: 2024-05-15 21:09:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
GT Biopharma, Inc. IND clearance for GTB-3650, a 2nd generation nanobody TriKE® for treatment of CD33+ leukemia expected ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here